Skip to main content
Log in

Pulsed Dye Laser in the Treatment of Localized Scleroderma and Its Effects on CD34+ and Factor XIIIa+ Cells: An Immunohistochemical Study

  • Original Research Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Background

Localized scleroderma (morphea) is characterized by hardening and thickening of the dermis due to excessive collagen deposition. A decreased number of CD34+ cells and an increased number of Factor XIIIa+ cells are seen in the affected skin. The flashlamp pulsed dye laser (FLPDL) has been used in the treatment of localized morphea with promising results.

Objective

The purpose of this study was to evaluate the therapeutic effectiveness of the pulsed dye laser in localized scleroderma and to assess its effect on CD34+ cells, Factor XIIIa+ cells, and blood vessels.

Study Design

Thirty patients with plaque morphea were treated with a FLPDL (585 nm wavelength, 450 μs pulse duration). Fluence ranged from 7.5 to 8.5 J/cm2. Sessions were performed biweekly for a maximum of 6 months. Clinical, histopathologic, and immunohistochemical assessments were performed.

Results

Patients showed varying degrees of improvement of indurated skin. There was no worsening or further improvement at the treated sites during the follow-up assessments at 3, 6, and 12 months. An increased number of CD34+ cells were found in both the upper and the lower dermis, and a decreased number of Factor XIIIa+ cells were found in the lower dermis.

Conclusion

The FLPDL is effective in the treatment of morphea, as confirmed by the changes in the pathologic tissue and levels of CD34+ and Factor XIIIa+ cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. De Rie MA, Bos JD. Photo-chemotherapy for systemic and localized scleroderma. J Am Acad Dermatol. 2000;13:725–6.

    Article  Google Scholar 

  2. Skobieranda K, Helm F. Decreased expression of the human progenitor cell antigen (CD34) in morphea. Am J Dermatopathol. 1995;17:471–5.

    Article  PubMed  CAS  Google Scholar 

  3. Headington JT, Cerio R. Dendritic cells and the dermis. Am J Dermatopathol. 1990;12:17–20.

    Article  Google Scholar 

  4. Anderson RP, Parrish JA. Precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–7.

    Article  PubMed  CAS  Google Scholar 

  5. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flash lamp pumped pulsed dye laser. Lancet. 1995;345:1198–200.

    Article  PubMed  CAS  Google Scholar 

  6. Alster TS, McMeekin TO. Improvement of facial acne scars by the 585 nm flash lamp pumped pulsed dye laser. J Am Acad Dermatol. 1996;35:79–81.

    Article  PubMed  CAS  Google Scholar 

  7. Eisen D, Alster TS. Use of a 585 nm pulsed dye laser for treatment of morphea. Dermatol Surg. 2002;28:615–6.

    Article  PubMed  Google Scholar 

  8. Camacho NR, Sanchez JE, Martin RF. Medium-dose UVA-1 phototherapy in localized scleroderma and its effect in CD 34-positive dendritic cells. J Am Acad Dermatol. 2001;45:697–9.

    Article  PubMed  CAS  Google Scholar 

  9. Jaworsky C. Connective tissue disease. In: Elder D, Elenitas R, Jaworsky C, et al., editors. Lever’s histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven; 1997. p. 274–8.

    Google Scholar 

  10. Adams EJ, Green JA, Clark AH. Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol. 1999;52(1):75–7.

    Article  PubMed  CAS  Google Scholar 

  11. Rowell NR, Goodfield MJ. Connective tissue disorders. In: Champion RH, Burton JL, Burns DA, et al., editors. Textbook of dermatology. 6th ed. Oxford: Blackwell Science; 1998. p. 2502.

    Google Scholar 

  12. Orringer JS, Voorhees JJ, Hamilton T. Dermal matrix remodeling after nonablative laser therapy. J Am Acad Dermatol. 2005;53(5):775–82.

    Article  PubMed  Google Scholar 

  13. Kreuter A, Hyun J, Stucker M, et al. A randomized controlled study of low-dose UVA-1, and narrow-band UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54:440–7.

    Article  PubMed  Google Scholar 

  14. Cerio R, Griffiths CME, Cooper KD. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol. 1989;121:421–32.

    Article  PubMed  CAS  Google Scholar 

  15. Sehgal VN, Srivastava G, Aggarwal AK. Localized scleroderma/morphea. Int Soc Dermatol. 2002;41:467–75.

    Article  Google Scholar 

Download references

Acknowledgments

No sources of funding were received to prepare this study. The authors have no conflicts of interest directly relevant to the content of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abeer Attia Tawfik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tawfik, A.A., Shokir, H., Soliman, M. et al. Pulsed Dye Laser in the Treatment of Localized Scleroderma and Its Effects on CD34+ and Factor XIIIa+ Cells: An Immunohistochemical Study. Am J Clin Dermatol 14, 235–241 (2013). https://doi.org/10.1007/s40257-013-0027-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-013-0027-7

Keywords

Navigation